Ocean Biomedical Inc. (NASDAQ: OCEA)’s stock price has soared by 18.27 in relation to previous closing price of 0.91. Nevertheless, the company has seen a gain of 18.55% in its stock price over the last five trading days. globenewswire.com reported 2024-10-15 that This license covers first-in-class small molecule YKL-40 inhibitors, including the lead molecule OAT-3912, which has shown potential therapeutic benefits in preclinical models in various cancers as well as inflammatory and fibrotic diseases, offering a novel approach to treating these conditions. In addition, the license covers a patent pending for a molecular screening test for further the continuation of the program and the development of new YKL-40 inhibitors.
Is It Worth Investing in Ocean Biomedical Inc. (NASDAQ: OCEA) Right Now?
OCEA has 36-month beta value of 1.50. Analysts have mixed views on the stock, with 1 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for OCEA is 9.14M, and currently, short sellers hold a 2.01% ratio of that float. The average trading volume of OCEA on October 16, 2024 was 59.56K shares.
OCEA’s Market Performance
OCEA stock saw an increase of 18.55% in the past week, with a monthly gain of 9.11% and a quarterly increase of -12.90%. The volatility ratio for the week is 7.49%, and the volatility levels for the last 30 days are 10.01% for Ocean Biomedical Inc. (OCEA). The simple moving average for the past 20 days is 14.98% for OCEA’s stock, with a -28.36% simple moving average for the past 200 days.
OCEA Trading at 7.87% from the 50-Day Moving Average
After a stumble in the market that brought OCEA to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -86.14% of loss for the given period.
Volatility was left at 10.01%, however, over the last 30 days, the volatility rate increased by 7.49%, as shares surge +6.93% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -4.42% lower at present.
During the last 5 trading sessions, OCEA rose by +18.55%, which changed the moving average for the period of 200-days by +39.61% in comparison to the 20-day moving average, which settled at $0.9393. In addition, Ocean Biomedical Inc. saw 63.64% in overturn over a single year, with a tendency to cut further gains.
Stock Fundamentals for OCEA
The total capital return value is set at 0.18. Equity return is now at value -678.22, with -176.47 for asset returns.
Based on Ocean Biomedical Inc. (OCEA), the company’s capital structure generated -0.19 points at debt to capital in total, while cash flow to debt ratio is standing at -0.49. The debt to equity ratio resting at -0.16. The interest coverage ratio of the stock is -5.55.
Currently, EBITDA for the company is -0.96 million with net debt to EBITDA at -2.07. The liquidity ratio also appears to be rather interesting for investors as it stands at 0.03.
Conclusion
To put it simply, Ocean Biomedical Inc. (OCEA) has had a mixed performance in recent times. Analysts have a bullish opinion on the stock, with some rating it as a “buy” and others as a “hold”. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
